Neuroprotection Market Size

Neuroprotection Market Size

Neuroprotection Market size was valued at around USD 38.3 billion in 2023 and is estimated to reach over USD 70.7 billion by 2032. Neuroprotection refers to substances or interventions aimed at safeguarding neuron structure and function in the brain and nervous system. Its goal is to hinder the progression of neurodegenerative diseases, reduce injury damage, and enhance overall nervous system health. The global prevalence of neurological disorders, such as Alzheimer's, Parkinson's, and multiple sclerosis, is on the rise due to factors such as aging populations, lifestyle changes, and improved diagnostic methods.

According to Alzheimer's Disease International (ADI), the global dementia population exceeded 55 million in 2020. Projections suggest it will almost double every 20 years, reaching 78 million by 2030 and 139 million by 2050, with the majority of this rise occurring in developing countries. Currently, 60% of people with dementia are in low and middle-income nations, expected to increase to 71% by 2050. These conditions cause progressive neuron damage and impaired nervous system function, leading to a growing demand for neuroprotection treatments.
 

Growing investments in research and development by pharmaceutical companies, academic institutions, and government agencies are driving innovation in neuroprotection therapeutics, particularly for conditions such as Alzheimer's, and Parkinson’s disease therapeutics. This leads to the development of novel drugs, therapies, and technologies targeting neuroprotection, thus expanding the market.